verified SJR 3,771 · Q1 • database Scopus / SJR & Web of Science indexed

United Kingdom · Elsevier Ltd

workspace_premium Q1 — Pharmacology lock Subscription Unclaimed

Trends in Pharmacological Sciences

Trends in Pharmacological Sciences is a journal indexed in SJR in Pharmacology and Toxicology with an H index of 252. It has an SJR impact factor of 3,771 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,771.

Trends in Pharmacological Sciences focuses its scope in these topics and keywords: receptor, gpr, implications, py, cancer, centurynew, family, intake, capecitabine, actions, ...

ISSN: 0165-6147

Editorial: Elsevier Ltd

Category: Pharmacology

Indexation: verifiedScopus / SJR verifiedWeb of Science

Unclaimed profile — some fields may be incomplete.

open_in_new Portal NPD menu_book Guidelines NPD

schedule Datos CoP · solo campos en BD

SJR Impact Factor trending_up

3,771 Q1

H-index 252

Tasa de Aceptación pie_chart

19% Selectiva

Fuente Acceptance_Rate

Tiempo a publicación hourglass_top

NPD

Campo Sin dato

Coste de Publicación (APC) payments

NPD Subscription

Ruta Non-OA NPD

Metrics

Campos Scimago / CoP — sin series inventadas

Scopus / SJR Web of Science

SJR Impact

3,771

H-index

252

Docs (year)

115

Docs 3y

304

Total refs

8163

Cites 3y

3758

Citable 3y

289

Cites/Doc 2y

12.38

Ref/Doc

70.98

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

—

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Caffeine protects against Parkinson's disease?

Welcome to the first European congress of pharmacology

Endogenous ligands and inverse agonism

Does a radiolabelled ligand bind to a homogeneous population of non-interacting receptor sites?

Dictionary of Cytokines

Development of novel drug delivery systems

Detoxification of a bacterial toxin by the toxin itself

Detection of receptor subtypes in radioligand binding studies Do saturation and homologous competition studies have different discriminatory power?

Delayed protection of the heart against ischaemia

Dawson and tricklebank reply

Cyclic ADP-ribose, the ryanodine receptor and Ca2+ release

Controlling the vasculature: Angiogenesis, anti-angiogenesis and vascular targeting of gene therapy

SHOW MORE ARTICLES

CCK receptor polymorphisms: an illustration of emerging themes in pharmacogenomics

A magic life of chemistry

Butler et al. reply

Biodiversity and new drugs

Beta3-adrenergic agonism: A new concept in human pharmacotherapy

Benefits of ethological analysis of behaviour

Approaches to the development of novel antihypertensive drugs: crucial role of the renal kallikrein-kinin system

Anderson and Coyle reply

Anandamide -the other side of the coin

An evolutionary view of drug-receptor interaction: the bioamine receptor family

Adenosine, antioxidant enzymes and cytoprotection

A scientific approach to herbal psychopharmacology

FAQS

In Country of Papers you can find SJR impact factor and other metrics to help you decide on a Journal.